Showing 3081-3090 of 8660 results for "".
A Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.Make Adults Kids Again
https://practicaldermatology.com/series/editors-message/make-adults-kids-again/23789/Physician Spotlight: George Han, MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-george-han-md-phd/23666/Email Marketing: Why and How To Use It For Your Dermatology Practice
https://practicaldermatology.com/topics/practice-management/email-marketing-why-and-how-to-use-it-for-your-dermatology-practice/23641/Text and social media have not displaced traditional email marketing strategies.Physician Spotlight: Shani Francis, MD, MBA
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-shani-francis-md-mba/23575/New in My Practice: OTC/New Products
https://practicaldermatology.com/columns/new-products/new-in-my-practice-otcnew-products-1/23561/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-24/23525/Toxic Attitudes Toward Skin Bleaching
https://practicaldermatology.com/conferences/aad-2021/toxic-attitudes-toward-skin-bleaching/19925/Unregulated ingredients intended for skin lightening and bleaching range from the toxic to the simply unproven. Seemal Desai, MD says dermatologists should educate patients about physician-recommended, well-studied treatments and the risks of unregulated products. He highlights increased attention tWomen in Dermatology: Amy Brodsky, MD, FAAD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-amy-brodsky-md-faad/23470/Women In Dermatology with Kim Nichols, MD, FAAD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-with-kim-nichols-md-faad/23434/